Litcius/Paper detail

Trifluoromethylpyridine 1,3,4-Oxadiazole Derivatives: Emerging Scaffolds as Bacterial Agents

Gang Yu, Shunhong Chen, Shengxin Guo, Bixue Xu, Jian Wu

2021ACS Omega14 citationsDOIOpen Access PDF

Abstract

value of 7.2 μg/mL; this was superior to bismerthiazol (57.2 μg/mL). Collectively, our findings provide a foundation for the development of trifluoromethylpyridine 1,3,4-oxadiazole derivatives.

Topics & Concepts

Ralstonia solanacearumXanthomonas oryzaeEC50OxadiazoleAntibacterial activityBacterial wiltChemistryXanthomonasIn vitroMicrobiologyNuclear chemistryBacteriaBiochemistryBiologyOrganic chemistryPathogenGeneticsGenePlant Pathogenic Bacteria StudiesFungal Plant Pathogen ControlPlant Virus Research Studies
Trifluoromethylpyridine 1,3,4-Oxadiazole Derivatives: Emerging Scaffolds as Bacterial Agents | Litcius